obe-cel

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

obe-cel

Nov 30, 2024, 15:27 | Insight

Obe-cel CAR T Therapy Achieves High Response Rates in R/R B-cell ALL: FELIX Trial Results

Trial results supported recent FDA approval for patients with relapsed/refractory disease Patients with relapsed or…

Jun 2, 2024, 22:16 | Insight

ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia

Clinical trial results suggest new treatment options could reduce need for stem cell transplants and…

May 29, 2024, 15:16 | Blog

Chen Lin: Updated results from FELIX for obecabtagene autoleucel in B-ALL by Elias Jabbour et al

Chen Lin, Assistant Professor at Duke Cancer Institute, shared on X/Twitter: "Updated results from FELIX for…

All: 3 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023